Recent News
Catch up on the most recent news and press releases from Quansys Biosciences about our technology.
View our press releases, recent news, and other updates below.
NHP-specific ELISAs now available from Quansys Biosciences
Logan, UT. January 31st, 2023 - Research in certain animal models is crucial to understanding how a therapeutic functions and how safe it might be for use in humans. A critical model for many studies, including those involving drug development, is the non-human...
PATH and Quansys Bioscience release Enhanced Micronutrient Biomarker Assay
Logan, UT. May 31st, 2022 - Micronutrient deficiencies disproportionately affect women and children in low- and middle-income countries. Such deficiencies can lead to systemic and enduring morbidities in individuals and their children, and if left untreated can...
Four new assays for cytokine research
Arrays designed to measure cytokine responses of different sides of the immune system Logan, UT, April 25th, 2022 - Quansys Biosciences releases four new assays to measure cytokine responses of the human immune system. Each array is designed to measure cytokine...
Human SARS-CoV-2 IgG (5-plex) to measure antibodies against nucleocapsid
Quansys Biosciences releases multiplex assay to measure antibodies from vaccination and from natural infection Logan, UT, July 28, 2021 – Quansys Biosciences in Logan, Utah, has recently released their Q-Plex™ Human SARS-CoV-2 IgG (5-plex) multiplex ELISA to...
Launch with PATH to accelerate EED interventions
Published July 14, 2021 by PATH Effective and affordable new research diagnostic tool can measure up to 11 key biomarkers of environmental enteric dysfunction with a single test Quansys Biosciences and global health nonprofit PATH have collaborated to develop a...
FDA EUA for SARS-CoV-2 IgG Antibody Test
For Immediate Release Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be...
Human Serological SARS-CoV-2 (4-Plex) ELISA
For Immediate Release Quansys Biosciences Releases Multiplex Human Serological SARS-CoV-2 (4-plex) ELISA Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be used in surveillance studies. Logan, UT, April 8, 2020 — Quansys...
Quansys to present at Biomarkers & World CDx Conference
For Immediate Release Contact: scall@quansysbio.com Quansys to present on multiplexing protein biomarkers in Precision Medicine at the 10th Annual, Clinical, Biomarkers & World CDx Conference Logan, UT, August 22, 2019—Quansys Biosciences, Inc. a pioneer in...
Lower price for nutrition assessment tool
PATH and Quansys Biosciences, Inc. improve access of the Q-Plex™ Human Micronutrient Array for low- and middle-income countries with a new price of US$1.43 per analyte, making it even more affordable and accessible to the countries that need it most.
AKURIO Islet Hormones multiplex assay
Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide, and proinsulin. The assay provides accurate measurements with high specificity – giving well-designed studies a fast track to scientific advances.